factor

(redirected from factor VIII activity)
Also found in: Dictionary, Thesaurus, Medical, Financial, Encyclopedia.
Related to factor VIII activity: Factor VIII deficiency

Factor

An event, circumstance, influence, or element that plays a part in bringing about a result.

A factor in a case contributes to its causation or outcome. In the area of Negligence law, the factors, or chain of causation, are important in determining whether liability ensues from a particular action done by the defendant.

factor

n. 1) a salesman who sells in his/her own name on behalf of others, taking a commission for services. 2) something that contributes to the result.

factor

(Commission merchant), noun agent, broker, commercial agent, delegate, deputy, envoy, interagent, manager, medium, middleman, one who sells for factorage, proctor, procurator, representative
Associated concepts: consignee, factors' lien

factor

(Ingredient), noun additive, agent, aid, aspect, cause, component, constituent, constitutive element, content, contributing force, determinant, element, elementary unit, feature, integral part, part, portion, segment, unit
See also: aspect, broker, cause, characteristic, component, constituent, dealer, deputy, determinant, element, feature, ingredient, member, part, plenipotentiary, portion, procurator, reason, represent, substitute

factor

1 a mercantile agent. An agent who is in the ordinary course of business entrusted with goods or documents of title representing goods with a view to their sale. A factor has a lien over goods entrusted to him; this lien covers any claims he may have against his principal arising out of the agency. Most factors will be mercantile agents (and have the powers of such) for the purposes of the Factors Act 1889. Under this Act, in certain circumstances a factor may pass a good title to goods entrusted to him.
2 an institution to whom a company assigns its book debts (see FACTORING).
3 in Scotland a landlord or superior's agent.
References in periodicals archive ?
Despite much discussion, consensus has not been reached on how to interpret high factor VIII activity.
The kinetics, duration and magnitude of AAV-mediated Factor VIII activity in individuals with hemophilia A will be determined and correlated to an appropriate BMN 270 dose.
In this case, the initial VWD testing panel identified significantly decreased plasma von Willebrand factor ristocetin cofactor activity (VWF:RCo), with a discordantly low ratio of VWF:RCo to von Willebrand factor antigen level (VWF:Ag) and normal coagulation factor VIII activity, suggesting types 2A, 2B, or 2M VWD (or acquired von Willebrand syndrome).
6-10 The reduction in factor VIII activity secondary to vWD was not ruled out by measuring the vWF:Ag and Ricof activity and since the BT may be normal in vWD we may have missed vWD in some instances.
Factor VIII activity levels increased in three patients above baseline, up to 4% of normal in one patient and up to 1%-2% of normal in two patients.
The product includes a recombinant analogue of porcine FVIII that allows physicians to manage the treatment's efficacy and safety by measuring factor VIII activity levels in addition to clinical evaluations.
Clotting factor VIII activity was below the detection limit (<5 IU/dL; reference interval, 70-150 IU/dL), and the activity of factor XII was slightly reduced (53 IU/dL, reference interval, 70-150 IU/dL).